Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Johanna Edlmayr"'
Autor:
Rudolf Valenta, Dieter Blaas, Beatrix Pfanzagl, Daniel Andergassen, Katarzyna Niespodziana, Johanna Edlmayr
Publikováno v:
Archives of Virology; Vol 159
HRV89, a major-group rhinovirus, uses intercellular adhesion molecule 1 (ICAM-1) for cell entry, while minor-group HRV2 uses the LDL receptor for clathrin-mediated endocytosis. Entry of HRV89 into HeLa epithelial cells was found to be inefficient, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9617881d4cf24ee792e51b212d3990b
https://doi.org/10.1007/s00705-013-1797-1
https://doi.org/10.1007/s00705-013-1797-1
Autor:
D Blaas, Vladislav Krzyzanek, Rudolf Valenta, Margit Focke-Tejkl, M Grote, Johanna Edlmayr, T Popow-Kraupp, Katarzyna Niespodziana
Publikováno v:
European Respiratory Journal. 37:44-52
Human rhinoviruses (HRVs) are the major cause of the common cold and account for 30-50% of all acute respiratory illnesses. Although HRV infections are usually harmless and invade only the upper respiratory tract, several studies demonstrate that HRV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0d46fe1af6b62f31e7e32e0604f35bf
https://doi.org/10.1183/09031936.00149109
https://doi.org/10.1183/09031936.00149109
Autor:
Johanna, Edlmayr, Katarzyna, Niespodziana, Margarete, Focke-Tejkl, Birgit, Linhart, Rudolf, Valenta
Publikováno v:
Current topics in microbiology and immunology. 352
IgE-mediated allergies affect more than 25% of the population. Allergen-specific immunotherapy (SIT) is an antigen-specific and disease-modifying form of treatment. It is based on the therapeutic administration of the disease-causing allergens to all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b40c8cc42cc7c0bf9113942f3ca94a47
https://pubmed.ncbi.nlm.nih.gov/21626347
https://pubmed.ncbi.nlm.nih.gov/21626347
Autor:
Johanna Edlmayr, Birgit Linhart, Margarete Focke-Tejkl, Rudolf Valenta, Katarzyna Niespodziana
Publikováno v:
Vaccines against Allergies ISBN: 9783642200533
IgE-mediated allergies affect more than 25% of the population. Allergen-specific immunotherapy (SIT) is an antigen-specific and disease-modifying form of treatment. It is based on the therapeutic administration of the disease-causing allergens to all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25ae83c4761ee236595f8aa9fcf7574a
https://doi.org/10.1007/82_2011_130
https://doi.org/10.1007/82_2011_130
Autor:
Josef Thalhamer, Birgit Linhart, Michael Kneidinger, Raffaela Campana, Johanna Edlmayr, Kerstin Westritschnig, Theresia Popow-Kraupp, Angelika Stoecklinger, Margarete Focke-Tejkl, Sandra Scheiblhofer, Rudolf Valenta, Peter Valent, Katarzyna Niespodziana
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 182(10)
Allergens and rhinovirus infections are among the most common elicitors of respiratory diseases. We report the construction of a recombinant combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived VP1, the surface protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d171863399ba682aa05501582a4bdc17
https://pubmed.ncbi.nlm.nih.gov/19414783
https://pubmed.ncbi.nlm.nih.gov/19414783